TBRG1
Transforming growth factor beta regulator 1
Also known as: FLJ14621, NIAM, TB-5, TBRG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3YBR2
- Gene
- TBRG1
- Ensembl
- ENSG00000154144
- Chromosome
- 11
- Canonical length
- 411 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Involved in several processes, including DNA replication; protein localization to nucleoplasm; and protein stabilization. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
411 residues, UniProt reviewed canonical sequence.
>Q3YBR2|TBRG1
1 MSLLDGLASS PRAPLQSSKA RMKKLPKKSQ NEKYRLKYLR LRKAAKATVF ENAAICDEIA
61 RLEEKFLKAK EERRYLLKKL LQLQALTEGE VQAAAPSHSS SLPLTYGVAS SVGTIQGAGP
121 ISGPSTGAEE PFGKKTKKEK KEKGKENNKL EVLKKTCKKK KMAGGARKLV QPIALDPSGR
181 PVFPIGLGGL TVYSLGEIIT DRPGFHDESA IYPVGYCSTR IYASMKCPDQ KCLYTCQIKD
241 GGVQPQFEIV PEDDPQNAIV SSSADACHAE LLRTISTTMG KLMPNLLPAG ADFFGFSHPA
301 IHNLIQSCPG ARKCINYQWV KFDVCKPGDG QLPEGLPEND AAMSFEAFQR QIFDEDQNDP
361 LLPGSLDLPE LQPAAFVSSY QPMYLTHEPL VDTHLQHLKS PSQGSPIQSS DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TBRG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 6.5 nTPM
Expression across tissuesHPA
Tissue
- spleen: 6.5 nTPM
- lymph node: 6 nTPM
- duodenum: 5.8 nTPM
- tonsil: 5.7 nTPM
- skeletal muscle: 5.6 nTPM
- appendix: 5.1 nTPM
Single-cell type
- adrenal cortex cells: 222 nCPM
- enterocytes: 182 nCPM
- leydig cells: 181 nCPM
- epididymal principal cells: 168 nCPM
- t-cells: 142 nCPM
- foveolar cells: 136 nCPM
Immune cell
- eosinophil: 35 nTPM
- memory B-cell: 34 nTPM
- neutrophil: 33 nTPM
- basophil: 31 nTPM
- naive B-cell: 31 nTPM
- T-reg: 28 nTPM
Brain region
- basal ganglia: 13 nTPM
- cerebral cortex: 8.9 nTPM
- white matter: 8.1 nTPM
- hippocampal formation: 7.6 nTPM
- hypothalamus: 7.1 nTPM
- amygdala: 6.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TBRG1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 74 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.81
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA replication
- negative regulation of cell population proliferation
- protein localization to nucleoplasm
- protein stabilization
- regulation of cell cycle
Cellular components
Protein domainsUniProt · Pfam · InterPro
- FY-rich, N-terminal
- FY-rich, C-terminal
- F/Y-rich N-terminus
- F/Y rich C-terminus
- Transforming growth factor beta regulator 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TBRG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TBRG1 as an antibody target. Whether an autoantibody or antibody against TBRG1 could matter depends on whether native TBRG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TBRG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TBRG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...